Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population.
Jha A, Ling A, Millo C, Gupta G, Viana B, Lin FI, Herscovitch P, Adams KT, Taïeb D, Metwalli AR, Linehan WM, Brofferio A, Stratakis CA, Kebebew E, Lodish M, Civelek AC, Pacak K. Jha A, et al. Among authors: millo c. Eur J Nucl Med Mol Imaging. 2018 May;45(5):787-797. doi: 10.1007/s00259-017-3896-9. Epub 2017 Dec 4. Eur J Nucl Med Mol Imaging. 2018. PMID: 29204718 Free PMC article.
Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.
Janssen I, Blanchet EM, Adams K, Chen CC, Millo CM, Herscovitch P, Taieb D, Kebebew E, Lehnert H, Fojo AT, Pacak K. Janssen I, et al. Among authors: millo cm. Clin Cancer Res. 2015 Sep 1;21(17):3888-95. doi: 10.1158/1078-0432.CCR-14-2751. Epub 2015 Apr 14. Clin Cancer Res. 2015. PMID: 25873086 Free PMC article.
PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.
Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, Adams KT, Wolf KI, Herscovitch P, Fojo AT, Buchmann I, Kebebew E, Pacak K. Janssen I, et al. Among authors: millo cm. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1784-91. doi: 10.1007/s00259-016-3357-x. Epub 2016 Mar 21. Eur J Nucl Med Mol Imaging. 2016. PMID: 26996779 Free PMC article.
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
Blanchet EM, Martucci V, Millo C, Chen CC, Herscovitch P, Pacak K. Blanchet EM, et al. Among authors: millo c. Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1928-9. doi: 10.1007/s00259-013-2507-7. Epub 2013 Jul 24. Eur J Nucl Med Mol Imaging. 2013. PMID: 23880966 Free PMC article. No abstract available.
Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.
Blanchet EM, Millo C, Martucci V, Maass-Moreno R, Bluemke DA, Pacak K. Blanchet EM, et al. Among authors: millo c. Clin Nucl Med. 2014 Mar;39(3):243-50. doi: 10.1097/RLU.0000000000000289. Clin Nucl Med. 2014. PMID: 24152658 Free PMC article. Clinical Trial.
83 results